Evaluating the Extent of Reusability of CYP2C19 Genotype Data among Patients Genotyped for Antiplatelet Therapy Selection

PURPOSE. Genotype-guided antiplatelet therapy is increasingly being incorporated into clinical care. The purpose of this study is to determine the extent to which patients initially genotyped for CYP2C19 to guide antiplatelet therapy were prescribed additional medications affected by CYP2C19. METHOD...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Genet Med
Main Authors: Beitelshees, Amber L., Stevenson, James M., El Rouby, Nihal, Dillon, Chrisly, Empey, Philip E., Fielstein, Elliot M., Johnson, Julie A., Limdi, Nita A., Ong, Henry H., Franchi, Francesco, Angiolillo, Dominick P., Peterson, Joshua F., Rosenman, Marc B., Skaar, Todd C., Tuteja, Sony, Cavallari, Larisa H.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7606808/
https://ncbi.nlm.nih.gov/pubmed/32678355
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41436-020-0894-2
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados